Mangalam Drugs And Organics Ltd vs Windlas Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Mangalam Drugs and Organics Ltd is ₹ 30.38 as of 18 May 15:30 . The P/E Ratio of Mangalam Drugs and Organics Ltd changed from 17.5 on March 2025 to 0 on March 2023 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Windlas Biotech Ltd changed from 18.3 on March 2024 to 11.1 on March 2023 . This represents a CAGR of -9.52% over 5 years The Market Cap of Mangalam Drugs and Organics Ltd changed from ₹ 146.65 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Windlas Biotech Ltd changed from ₹ 1065 crore on March 2024 to ₹ 479.02 crore on March 2023 . This represents a CAGR of -14.78% over 5 years The revenue of Mangalam Drugs and Organics Ltd for the Mar '26 is ₹ 67.38 crore as compare to the Dec '25 revenue of ₹ 58.6 crore. This represent the growth of 14.98% The revenue of Windlas Biotech Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 237.67 crore. This represent the decline of -100% The ebitda of Mangalam Drugs and Organics Ltd for the Mar '26 is ₹ -5.53 crore as compare to the Dec '25 ebitda of ₹ -1.32 crore. This represent the growth of 318.94% The ebitda of Windlas Biotech Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 28.95 crore. This represent the decline of -100% The net profit of Mangalam Drugs and Organics Ltd changed from ₹ 2.68 crore to ₹ -13.42 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Windlas Biotech Ltd changed from ₹ 13.48 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Mangalam Drugs and Organics Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Windlas Biotech Ltd changed from 19.79 % on March 2022 to 20.04 % on March 2025 . This represents a CAGR of 0.31% over 4 years .

About Mangalam Drugs and Organics Ltd

Mangalam Drugs and Organics Limited was initially incorporated as 'Advent Pharma Private Limited' on April 18, 1972.
On July 1, 1997, the Company changed the name from Advent Pharma Private Limited to Mangalam Drugs and Organics Private Limited.
Thereafter, it converted the status into a Public Limited Company, changing the name to Mangalam Drugs and Organics Limited on August 10, 2001.
The company was established to set up a plant for manufacture of organic and inorganic chemicals. The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates.
The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra.

About Windlas Biotech Ltd

Windlas Biotech Limited, formerly known as Windlas Biotech Private Limited was incorporated in 2001.
The Company got converted from a Private Limited to a Public Limited Company and the name of the Company was changed to Windlas Biotech Limited'.
A fresh Certificate of Incorporation dated April 15, 2021, granted by the Registrar of Companies, Uttarakhand at Dehradun. The Company is engaged in manufacturing and trading of pharmaceutical products.
Their manufacturing plants are located at Dehradun in Uttarakhand.
It has three distinct strategic business verticals (SBVs) mainly comprising of CDMO services and products; domestic trade generics and over-the-counter (OTC) brands; and exports. The Company commenced operations at Dehradun Plant -IV in 2010.

FAQs for the comparison of Mangalam Drugs and Organics Ltd and Windlas Biotech Ltd

Which company has a larger market capitalization, Mangalam Drugs and Organics Ltd or Windlas Biotech Ltd?

Market cap of Mangalam Drugs and Organics Ltd is 48 Cr while Market cap of Windlas Biotech Ltd is 1,604 Cr

What are the key factors driving the stock performance of Mangalam Drugs and Organics Ltd and Windlas Biotech Ltd?

The stock performance of Mangalam Drugs and Organics Ltd and Windlas Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mangalam Drugs and Organics Ltd and Windlas Biotech Ltd?

As of May 18, 2026, the Mangalam Drugs and Organics Ltd stock price is INR ₹30.38. On the other hand, Windlas Biotech Ltd stock price is INR ₹777.3.

How do dividend payouts of Mangalam Drugs and Organics Ltd and Windlas Biotech Ltd compare?

To compare the dividend payouts of Mangalam Drugs and Organics Ltd and Windlas Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.